EADV Podcast

In this episode of the EADV Podcast, Prof. Michela Starace, Chair of the EADV Hair Diseases Task Force, is joined by Task Force Co-Chairs Prof. Alexander Katoulis and Dr. Matilde Iorizzo to discuss current perspectives on scarring alopecias and the challenges of diagnosis and management.
The conversation explores the relationship between lichen planopilaris and frontal fibrosing alopecia, highlighting ongoing debates around their classification, clinical presentation, and treatment approaches. The speakers also discuss the value of trichoscopy in everyday practice, the importance of early recognition of inflammatory activity, and the role of consensus-driven guidance in supporting clinicians faced with complex cases.
Looking ahead, the experts examine emerging therapeutic strategies, including the potential role of JAK inhibitors, while reflecting on the need for further evidence and long-term data. The episode highlights the importance of recognising the emotional and psychosocial impact of hair disorders, while encouraging clinicians to adopt a patient-centred approach to care. Through practical insights, shared experiences, and discussion of emerging developments, the speakers underline the value of education, collaboration, and empathy in improving outcomes for people living with alopecia and other hair diseases.
References:
Seyed Jafari SM, Starace M, Katoulis A, et al.Management of classic lichen planopilaris: The EADV Task Force on Hair Diseases position statement.Journal of the European Academy of Dermatology and Venereology (JEADV). Published online 18 March 2026.DOI: 10.1111/jdv.70379.
Waśkiel-Burnat A, Starace M, Iorizzo M, Katoulis A, et al.Management of folliculitis decalvans: The EADV Task Force on Hair Diseases position statement.Journal of the European Academy of Dermatology and Venereology (JEADV). 2025;39(8):1385–1394.DOI: 10.1111/jdv.20687
Starace MVR, Pampaloni F, Iorizzo M, Katoulis A, et al.Delphi Consensus on the Distinct Clinical and Histopathological Features of Lichen Planopilaris and Frontal Fibrosing Alopecia: Insights From the Hair Diseases EADV Task Force.International Journal of Dermatology. 2025;64(7):1246–1254.DOI: 10.1111/ijd.17780.

In this JEADV Takeaway, Dr. Willemijn Witkam takes you through "Healthy plant-based dietary pattern is associated with a lower risk of rosacea" by Zhang et al., published in the July 2026 issue of JEADV.
The full article is available here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.70163

Join Prof. Carle Paul  as he presents his selection of Editor’s Picks from the July 2026 issue: 
An expert consensus on treat-to-target criteria for chronic prurigo
Evidence-based European guidelines for the treatment of acne
Denifanstat for moderate to severe acne: a potential alternative to isotretinoin?
JAK inhibitors for non-infectious granulomatous skin diseases
Read the Editor's Picks here: https://doi.org/10.1111/jdv.70472

In this special Pride Month episode of the EADV Podcast, Dr. Tiago Matos and Prof. Myrto Trakatelli explore why inclusion, visibility, and affirming care matter in dermatology and venereology today more than ever. Through an open and honest conversation, they discuss how everyday clinical interactions, communication, and representation can directly influence patient trust, healthcare access, and long-term outcomes for LGBTQI+ communities.
From creating safer consultation spaces to recognising unconscious bias and improving medical education, the speakers reflect on the responsibility healthcare professionals have in delivering truly patient-centred care. The discussion also highlights the importance of allyship, empathy, and visibility in helping patients feel seen, respected, and supported throughout their healthcare journey.
This episode highlights the value of honesty, vulnerability, and allyship in medicine, while encouraging healthcare professionals to create safer and more welcoming environments for every patient. A thoughtful discussion on representation, education, and the human side of dermatological and venereological care.

Join Prof. Rolland Gyulai as he presents his selection of Editor’s Picks from the June 2026 issue: 
 
First oral TNFR1 inhibitor for mild-to-moderate psoriasis
Adjuvant treatment with immune checkpoint inhibitors - no benefit in acral melanomas
Simple biomarkers predict favourable treatment response
Mogamulizumab-associated rash – new insights into pathogenesis
Read the Editor's Picks here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.70448

In this episode of the EADV Podcast, Dr. Antonio Torrelo speaks with Dr. Andrea Diociaiuti, contributor to the recent JEACP Special issue on cutaneous mosaicism, to explore one of the most fascinating concepts in dermatology and genetics. Together, they discuss how mosaicism shapes the skin, the clinical patterns that help physicians recognise these conditions, and how advances in genetic sequencing are transforming diagnosis and patient care. The conversation also delves into the broader implications of mosaicism beyond the skin, the importance of careful clinical observation, and the increasing potential of precision medicine and targeted therapies. This episode offers listeners an accessible and forward-looking overview of a rapidly evolving field that is changing the way dermatologists understand genetics, skin biology, and personalised medicine.
 
Read the Special Issue: https://onlinelibrary.wiley.com/toc/27686566/2025/4/3
 

Join Prof. Carle Paul as he presents his selection of Editor’s Picks from the May 2026 issue: 
Management of cutaneous immune adverse events associated with immune check point inhibitors (ICI)
Pregnancy-associated melanoma: no additional risk of progression
Long-term treatment with nemolizumab for atopic dermatitis
Management of cutaneous lupus: state of the art
 
Read the Editor's Picks here: https://onlinelibrary.wiley.com/doi/10.1111/jdv.70409

In this episode of the EADV Podcast, Dr. Azael Freites Martinez is joined by Prof. Zoe Apalla and Dr. Vincent Sibaud for a practical discussion on the dermatologic adverse events associated with immune checkpoint inhibitors. Together, they explore why the skin is so commonly affected, how to recognise the most frequent reactions in daily practice, and when cancer patients should be referred to a dermatologist.
The conversation also highlights current management strategies for pruritus, eczematous, psoriasiform and lichenoid reactions, with a focus on accurate diagnosis, multidisciplinary collaboration, and the growing role of targeted and biologic therapies in supportive oncodermatology.
The episode closes with an important reminder: many of these skin reactions are manageable, and timely dermatologic care can make a meaningful difference to both quality of life and cancer treatment continuity.